Phio Pharmaceuticals Corp. (PHIO)
1.13
+0.01
(+0.89%)
USD |
NASDAQ |
Aug 28, 16:00
1.12
-0.01
(-0.88%)
After-Hours: 20:00
Phio Pharmaceuticals Cash from Operations (Quarterly) : -4.035M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.035M |
| March 31, 2026 | -4.003M |
| December 31, 2025 | -2.079M |
| September 30, 2025 | -2.085M |
| June 30, 2025 | -2.54M |
| March 31, 2025 | -1.275M |
| December 31, 2024 | -1.371M |
| September 30, 2024 | -1.953M |
| June 30, 2024 | -1.777M |
| March 31, 2024 | -2.011M |
| December 31, 2023 | -2.37M |
| September 30, 2023 | -2.90M |
| June 30, 2023 | -2.771M |
| March 31, 2023 | -2.708M |
| December 31, 2022 | -2.705M |
| September 30, 2022 | -3.526M |
| June 30, 2022 | -2.429M |
| March 31, 2022 | -3.469M |
| December 31, 2021 | -2.471M |
| September 30, 2021 | -3.099M |
| June 30, 2021 | -3.255M |
| March 31, 2021 | -3.033M |
| December 31, 2020 | -2.623M |
| September 30, 2020 | -1.971M |
| June 30, 2020 | -2.032M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.176M |
| December 31, 2019 | -2.546M |
| September 30, 2019 | -1.991M |
| June 30, 2019 | -1.933M |
| March 31, 2019 | -2.175M |
| December 31, 2018 | -1.746M |
| September 30, 2018 | -2.007M |
| June 30, 2018 | -1.86M |
| March 31, 2018 | -1.907M |
| December 31, 2017 | -2.201M |
| September 30, 2017 | -2.197M |
| June 30, 2017 | -2.317M |
| March 31, 2017 | -2.799M |
| December 31, 2016 | -1.372M |
| September 30, 2016 | -1.603M |
| June 30, 2016 | -1.86M |
| March 31, 2016 | -2.925M |
| December 31, 2015 | -1.582M |
| September 30, 2015 | -1.963M |
| June 30, 2015 | -1.80M |
| March 31, 2015 | -1.972M |
| December 31, 2014 | -1.595M |
| September 30, 2014 | -1.766M |
| June 30, 2014 | -2.017M |
| March 31, 2014 | -2.38M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Imunon, Inc. | -3.026M |
| Agenus, Inc. | -31.20M |
| Amgen, Inc. | 4.002B |
| Anika Therapeutics, Inc. | -0.684M |
| BioCryst Pharmaceuticals, Inc. | 103.98M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -12.21M |
| Free Cash Flow Per Share (Quarterly) | -0.3473 |
| Free Cash Flow to Equity (Quarterly) | -4.035M |
| Free Cash Flow to Firm (Quarterly) | -4.035M |
| Free Cash Flow Yield | -107.2% |